Anlon Healthcare
MAINBOARDOpen
MAINBOARDOpen
IPO Closes in
--Days
--Hours
--Minutes
--Seconds
IPO Timeline
Issue open date
26 Aug 2025Issue close date
29 Aug 2025UPI mandate deadline
29 Aug 2025Allotment finalization
1 Sep 2025Refund initiation
2 Sep 2025Share credit
2 Sep 2025Listing date
3 Sep 2025Mandate end date
15 Sep 2025Lock-in end date for anchor investors (50%)
1 Oct 2025Lock-in end date for anchor investors (remaining)
30 Nov 2025Grey Market Premium Trend
₹5
Current GMP
₹96
Est. Listing Price
5.5%
Est. Listing Gain
₹86 - ₹91
Price Band
GMP History
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 25 Aug | ₹5 | ₹96 | 5.49% |
| 24 Aug | ₹5 | ₹96 | 5.49% |
| 23 Aug | ₹0 | ₹91 | 0.00% |
| 22 Aug | ₹0 | ₹91 | 0.00% |
| 21 Aug | ₹0 | ₹91 | 0.00% |
| 20 Aug | ₹0 | ₹91 | 0.00% |
IPO Closes in
--Days
--Hours
--Minutes
--Seconds
💸
IPO Subscription Status
| Category | Times | Allotment Chances |
|---|---|---|
| HNIs (Total) | 2.04 | 49.0% |
| bHNI | 1.35 | 74.1% |
| sHNI | 3.42 | 29.2% |
| QIBs | 1.01 | 99.0% |
| Retail | 22.06🔥 | 4.5% |
Last updated: 28 August'25 11:14AM
Key Dates
Open
26 Aug 2025Close
29 Aug 2025Listing
3 Sep 2025Quick Stats
Lot Size:164 shares
Issue Details
About the Company
Anlon Healthcare, founded in 2013, is a pharmaceutical company based in Rajkot, Gujarat. The company began its manufacturing operations in 2017 and is engaged in the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and nutraceutical compounds. With a focus on quality and compliance, the company operates a single manufacturing facility that is ISO 9001:2015, GMP, and WHO-GMP certified. Anlon Healthcare serves pharmaceutical companies across India and exports to select international markets.
Strengths
- Diverse product portfolio with scalable business operations.
- Experienced promoters and competent management team.
- High entry barriers due to strict approval standards.
- In-house testing ensures consistent quality and compliance.
- Emphasis on Quality, Environment, Health, and Safety (QEHS).
Risks
- High dependency on single manufacturing unit in Rajkot, Gujarat.
- Revenue concentration from top few pharmaceutical industry customers.
- Limited experience in complex pharma intermediates manufacturing.
- Heavy reliance on select suppliers from western India.
- Delay in regulatory approvals can halt operations and revenue.
Anlon Healthcare IPO – Frequently Asked Questions
- The price band for the Anlon Healthcare IPO is set at ₹86 to ₹91 per share.
- The Anlon Healthcare IPO opens on August 26, 2025 and closes on August 29, 2025.
- The tentative listing date for the Anlon Healthcare IPO is September 3, 2025.
- You can apply for the Anlon Healthcare IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Anlon Healthcare, enter lot quantity and UPI ID, then approve the mandate.
- The lot size for the Anlon Healthcare IPO is 164 shares. Investors must apply for at least one lot (i.e., 164 shares).